Corrigendum: Pyrazolyl-s-triazine with indole motif as a novel of epidermal growth factor receptor/cyclin-dependent kinase 2 dual inhibitors

Front Chem. 2023 Jan 11:10:1131801. doi: 10.3389/fchem.2022.1131801. eCollection 2022.

Ihab Shawish^{1

2}, Mohamed S Nafie³, Assem Barakat², Ali Aldalbahi², Hessa H Al-Rasheed², M Ali², Walhan Alshaer⁴, Mazhar Al Zoubi⁵, Samha Al Ayoubi¹, Beatriz G De La Torre^{6

7}, Fernando Albericio^{7

8}, Ayman El-Faham⁹

¹ Department of Math and Sciences, College of Humanities and Sciences, Prince Sultan University, Riyadh, Saudi Arabia.
² Department of Chemistry, College of Science, King Saud University, Riyadh, Saudi Arabia.
³ Department of Chemistry, Faculty of Science, Suez Canal University, Ismaïlia, Egypt.
⁴ Cell Therapy Center, The University of Jordan, Amman, Jordan.
⁵ Department of Basic Medical Sciences, Faculty of Sciences, Yarmouk University, Irbid, Jordan.
⁶ KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
⁷ Peptide Science Laboratory, School of Chemistry and Physics, University of KwaZulu-Natal, Durban, South Africa.
⁸ CIBER-BBN (Networking Centre on Bioengineering, Biomaterials and Nanomedicine) and Department of Organic Chemistry, University of Barcelona, Barcelona, Spain.
⁹ Chemistry Department, Faculty of Science, Alexandria University, Alexandria, Egypt.

Abstract

[This corrects the article DOI: 10.3389/fchem.2022.1078163.].

Keywords: EGFR/CDK-2; anticancer profile; apoptosis; indole; pyrazolyl-s-triazine.